Otros idiomas Praxis Precision Medicines, Inc.

Acciones

PRAX

US74006W2070

Mercado cerrado - Nasdaq Otros sitios de cotización 22:00:00 26/04/2024			Varia. Cinco días.	Varia. 1 de enero.
54,8 ^USD	+3,63 %		+16,87 %	+145,96 %

08/04	PRAXIS PRECISION MEDICINES, INC. : Wedbush se mantiene neutral sin recomendación.	ZM
28/03	Praxis Precision Medicines fija el precio de una oferta pública de 200 millones de dólares	MT

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Praxis Precision Medicines : April 2024 Corporate Presentation	23/04
PRAXIS PRECISION MEDICINES TO PRESENT ON ULIXACALTAMIDE AT THE AMERICAN ACADEMY OF NEUROLOGY 2024 ANNUAL MEETING	15/04
Praxis Precision Medicines to Present on Ulixacaltamide at the American Academy of Neurology 2024 Annual Meeting	12/04
Certain Common Stock of Praxis Precision Medicines, Inc. are subject to a Lock-Up Agreement Ending on 11-APR-2024.	11/04
Certain Restricted Stock Units of Praxis Precision Medicines, Inc. are subject to a Lock-Up Agreement Ending on 11-APR-2024.	11/04
Certain Stock Options of Praxis Precision Medicines, Inc. are subject to a Lock-Up Agreement Ending on 11-APR-2024.	11/04
Praxis Precision Medicines to Participate in Upcoming April Conferences	05/04
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	02/04
Praxis Precision Medicines Prices $200 Million Public Offering	28/03
Praxis Precision Medicines, Inc. Announces Pricing of $200 Million Public Offering	28/03
Praxis Precision Medicines Plans Public Equity Offering	27/03
Praxis Precision Medicines, Inc. Announces Proposed Public Offering	27/03
Praxis Precision Medicines Reports Positive Results of PRAX-628 Study Evaluating Photo Paroxysmal Response (PPR) Achieving 100% Response in Treated Patients	26/03
Praxis Precision Medicines Reports Positive Results of PRAX-628 Study Evaluating Photo Paroxysmal Response Achieving 100% Response in Treated Patients	26/03
Praxis Precision Medicines to Host PRAX-628 Program Update	25/03
Praxis Precision Medicines Files $750 Million Mixed-Securities Shelf Registration	05/03
Praxis Precision Medicines, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	05/03
Praxis Precision Medicines : March 2024 Corporate Presentation	05/03
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results	05/03
Praxis Precision Medicines, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	05/03

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Praxis Precision Medicines, Inc.

Acciones

PRAX

US74006W2070

Otros idiomas

Filtros